Synovial Fluid Cell Profiling Identifies Distinct Inflammatory Phenotypes in Late-Onset Rheumatoid Arthritis and Polymyalgia Rheumatica - Top-Institutions - MDSpire

Cellular Analysis of Synovial Fluid Reveals Unique Inflammatory Profiles in Late-Onset Rheumatoid Arthritis and Polymyalgia Rheumatica

  • By

  • Shigeru Tanaka

  • Takahiro Sugiyama

  • Shuhei Kameda

  • Tatsuro Takahashi

  • Masahiro Yasui

  • Yuki Hayashi

  • Tomoaki Ida

  • Yuhi Yoshida

  • Soichiro Kubota

  • Takashi Ito

  • Takahiro Kageyama

  • Daiki Nakagomi

  • Kei Ikeda

  • Shin-Ichiro Kagami

  • Hiroshi Nakajima

  • July 1, 2026

Share

Top Institutions in Rheumatology

Brief introduction explaining scope and methodology.

  • #1

    Chiba University
    Chiba University

    Chiba, Chiba

    Key Differentiators

    • Rheumatology

  • #2

    Oulu University Hospital
    Oulu University Hospital

    Oulu, Oulu

    Key Differentiators

    • Rheumatology

  • #3

    Kuopio University Hospital
    Kuopio University Hospital

    Kuopio, North Savo

    Key Differentiators

    • Rheumatology

  • #4

    Chongqing Southwest Hospital
    Chongqing Southwest Hospital

    Chongqing, Chongqing

    Key Differentiators

    • Rheumatology

Original Source(s)

Synovial Fluid Cell Profiling Identifies Distinct Inflammatory Phenotypes in Late-Onset Rheumatoid Arthritis and Polymyalgia Rheumatica

  • by Shigeru Tanaka, Takahiro Sugiyama, Shuhei Kameda, Tatsuro Takahashi, Masahiro Yasui, Yuki Hayashi, Tomoaki Ida, Yuhi Yoshida, Soichiro Kubota, Takashi Ito, Takahiro Kageyama, Daiki Nakagomi, Kei Ikeda, Shin-Ichiro Kagami, Hiroshi Nakajima

  • July 1, 2026

Related Content

When Bad Data Enters the Drug Pipeline

Federal prosecutors allege that a Florida physician and research staff fabricated clinical trial records that were submitted into database systems used to evaluate investigational drugs.

Systemic regulation of rheumatoid arthritis by mesenchymal stem cells: from immune homeostasis to microbiota modulation

RA Outcomes Improved in KURAMA Cohort

Ten-year observational data showed lower disease activity and functional disability coinciding with broader use of biologic and targeted synthetic therapies.